You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

androgen independent prostate cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Cancer Trial in Miami (FTLEAD, Ultra-Short-Term Androgen Deprivation Therapy with Relugolix, HypoLEAD)

Not yet recruiting
  • Prostate Cancer
  • FTLEAD
  • +3 more
  • Miami, Florida
    University of Miami
Oct 26, 2023

Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

Recruiting
  • Castrate Resistant Prostate Cancer
  • Chicago, Illinois
  • +2 more
Jul 19, 2022

Prostate Cancer Trial in Multiple Locations (Darolutamide 600 mg twice daily, Placebo 600 mg twice daily, Androgen deprivation

Recruiting
  • Prostate Cancer
  • Darolutamide 600 mg twice daily
  • +2 more
  • Multiple Locations, China
    Many Locations
Aug 2, 2022

Social Determinants of Cardiotoxicity in Prostate Cancer

Recruiting
  • Prostate Cancer
  • +3 more
  • Social Determinants of Health
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 19, 2023

Prostate Cancer, Androgen Deprivation Therapy, Radiotherapy Trial in Reggio Emilia (PE Intervention)

Completed
  • Prostate Cancer
  • +2 more
  • PE Intervention
  • Reggio Emilia, Emilia-Romagna, Italy
    Azienda USL-IRCCS di Reggio Emilia
Oct 17, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Pioglitazone 30 mg
  • Placebo
  • Buffalo, New York
    Diabetes and Endocrinology Research Center of WNY
Oct 26, 2022

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

Prostate Cancer, Sleep Disturbance, Fatigue Trial in Kansas City (teleCBT-I + SH/ReadiWatchTM, SH/ReadiWatchTM)

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • teleCBT-I + SH/ReadiWatchTM
  • SH/ReadiWatchTM
  • Kansas City, Kansas
    University of Kansas Cancer Center
Oct 12, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation

Recruiting
  • Prostate Cancer
  • Abemaciclib 150 MG by mouth twice daily
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB)
Mar 18, 2022

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

Not yet recruiting
  • Metastatic Prostate Cancer
  • 177Lu-DOTA-rosopatamb
  • (no location specified)
Aug 29, 2022

Advanced Prostate Cancer Trial in Hong Kong (Conventional IMRT, SBRT)

Recruiting
  • Advanced Prostate Cancer
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Sep 13, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (behavioral, other, procedure)

Active, not recruiting
  • Recurrent Prostate Cancer
  • Stage IV Prostate Cancer
  • behavioral dietary intervention
  • +5 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022

Prostate Cancer Trial in Louisville (Taxotere, Doxil)

Completed
Has Results
  • Prostate Cancer
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 29, 2019

Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

Not yet recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Oct 3, 2022

Prostate Cancer Trial (Dasatinib)

Withdrawn
  • Prostate Cancer
  • (no location specified)
Feb 23, 2022

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Recurrent Prostate Cancer Trial in Bern (Ultrahypofractionated salvage radiotherapy to a local recurrence after radical

Recruiting
  • Recurrent Prostate Cancer
  • Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy
  • Androgen deprivation therapy
  • Bern, Switzerland
    Inselgruppe AG, Inselspital
Mar 1, 2023

Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Apalutamide 60mg Tab
  • Androgen deprivation therapy(ADT)
  • Nanjing, Jiangsu, China
  • +2 more
Mar 17, 2023

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022